C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/505 (2006.01) A61P 25/16 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2468681
This invention relates to compounds having the structural formula (I) or pharmaceutically acceptable salts or solvates thereof, wherein R, R2 and R3 are as defined in the specification, pharmaceutical compositions thereof, and methods of treating stroke or central nervous system diseases by administering the compound of the present invention to a patient in need of such treatment.
L'invention concerne des composés de formule développée (I) ou des sels acceptables sur le plan pharmaceutique ou des solvates de ceux-ci, dans laquelle R, R?2¿ et R?3¿ sont tels que définis dans la description, ainsi que des compositions pharmaceutiques de ceux-ci et des méthodes de traitement d'accident vasculaire cérébral et de maladies du système nerveux central consistant à administrer le composé selon l'invention à un patient nécessitant un tel traitement.
Caldwell John P.
Matasi Julius J.
Neustadt Bernard R.
Silverman Lisa S.
Tulshian Deen
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
Schering Corporation
LandOfFree
Adenosine a2a receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Adenosine a2a receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Adenosine a2a receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1499871